We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OIG: HHS Must Clamp Down on Off-Label Drug Promotion
OIG: HHS Must Clamp Down on Off-Label Drug Promotion
October 3, 2012
Drugmakers could see a more forceful crackdown on off-label promotion, says a new Office of Inspector General (OIG) report that directs HHS to focus on the practice.